ArticleCancer medicine2024

METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression.

Wei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.